Biologics and Novel Therapies for Food Allergy

摘要

Food allergy is a significant public health burden with a significant increase in its prevalence over the last decades globally. In the United States, food allergy affects around 10% of adults and 8% of children.1?3 The potential risk of severe or fatal anaphylaxis, the associated anxiety and nutritional issues of the affected patients, and the significantly negative impact on quality of life all underscore the need for developing effective therapeutic options for food allergy.4,5 Although the current standard of care for most food allergy consists of avoiding the